Assessment of Blood Prostaglandin E2 Metabolite Levels among Infants Born Preterm with Patent Ductus Arteriosus: A Prospective Study, The Journal of Pediatrics, 276, (114285), (2025). https://doi ...

WE have recently seen 4 women with patent ductus arteriosus who had been treated for many years for aortic regurgitation because of enlargement of the left ventricle, a diastolic murmur along the l ...

Diseases & Conditions Patent Ductus Arteriosus (PDA) 2002 890196-overview ...

Patent ductus arteriosus (PDA) in preterm newborns prior to 28 weeks of gestation has led to many challenges regarding the type and timing of treatment regimens. A PDA results in increased ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management, a ...

Patent ductus arteriosus (PDA), one of the more common cardiac defects present at birth, is the persistence of an opening between the pulmonary artery and aorta. This opening is as a result of ...

The FDA approval of this device was supported by results of the ADO II AS trial, which evaluated the device in 50 patients with patent ductus arteriosus who were older than 3 days. Efficacy and ...

Current evidence on the safety and efficacy of endovascular closure of patent ductus arteriosus (PDA) appears adequate to support the use of this procedure provided that the normal arrangements are in ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management ...

Evidence-based recommendations on endovascular closure of patent ductus arteriosus. This involves placing a blocking device into the heart, which stays in place permanently and the body’s tissue grows ...